NIH R01 · 2025
Prenatal tobacco use is a pressing public health problem, placing individuals who use and their infants at greater risk of poor health outcomes relative to other populations. Co-use of tobacco and cannabis during pregnancy is also common and may hinder prenatal smoking cessation and postpartum tobacco abstinence. Depressive symptoms represent a modifiable factor related to discrimination, prenatal tobacco, and prenatal cannabis use that can be addressed to promote perinatal cessation and prevent relapse. Effective perinatal tobacco and cannabis use cessation interventions created in partnership with populations likely to use are needed. Accordingly, the proposed project is designed to…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.